Characterization of potent abcg2 inhibitor derived from chromone: from the mechanism of inhibition to human extracellular vesicles for drug delivery

HIGHLIGHTS

• who: Glaucio Valdameri and collaborators from the Federal University of Parana, Curitiba, PR, Brazil have published the paper: Characterization of Potent ABCG2 Inhibitor Derived from Chromone: From the Mechanism of Inhibition to Human Extracellular Vesicles for Drug Delivery, in the Journal: Pharmaceutics 2023, 1259 of 22/03/2023
• what: The authors report the characterization of a potent ABCG2 inhibitor namely chromone 4a (C4a). Considering thethe powerful useuse of of lipid nanoparticles (LNPs) a drugdelivery deliverysystem systemon onthe themarket marketand and in in development development , lipid nanoparticles (LNPs) asas a drug , in this work, the authors . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.